ADMA Biologics Inc
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Total Revenue 3,068 1,118 761
Cost of Revenue 2,023 669 208
Gross Profit 1,044 449 553
Operating Expenses
Research and Development 9,303 3,469 647
Sales, General and Admin. 6,783 4,889 4,530
Non-Recurring Items - - -
Other - - -
Operating Income (15,042) (7,909) (4,623)
Income From Continuing Operations
Add'l Income/Expense Items 133 21 2
Earnings Before Interest and Tax (14,909) (7,888) (4,621)
Interest Expense 618 31 1,603
Earnings Before Tax (15,527) (7,919) (6,224)
Income Tax - (618) (321)
Minority Interest - - -
Equity Earnings Unconsolidated Subsidiary - - -
Net Income Cont. Operations (15,527) (7,301) (5,903)
Non Recurring Events
Discontinued Operations - - -
Extraordinary Items - - -
Effect of Accounting Changes - - -
Other Items - - -
Net Income (15,527) (7,301) (5,903)
Preferred Stock and Other Adjustments - - -
Net Income Applicable to Common Shareholders (15,527) (7,301) (5,903)